SEC Form 4 · accession 0000899243-16-014977
Clovis Oncology, Inc. · CLVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Corwin Dale Hooks
Officer — See Remarks
Period of report
Mar 1, 2016
Accepted (ET)
Mar 2, 2016 · 4:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001466301
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $19.37 | Mar 1, 2016 | A | 10,000 | A | — | Mar 1, 2026 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1The option shall vest as to 25% of the shares on March 1, 2017, and the remainder shall vest in substantially equal installments over the 48 months immediately following such date.
Remarks
Senior Vice President and Chief Commercial Officer